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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma in pregnancy is a rare case, a dilemma in its management. This 
condition has a significant negative effect on pregnancy, given risk of premature birth, fetal defects and abortion.  
Case Report: 23-year-old woman with 13 weeks gestation age comes with swelling in both necks accompanied 
by nosebleeds. On nasoendoscopic examination, there was a mass at nasopharynx. Histopathological 
examination results a nasopharyngeal squamous cell carcinoma. 
Conclusion: The management of nasopharyngeal carcinoma in pregnancy is very complex, need for extensive 
multidisciplinary approach with experienced doctors in their respective fields. 
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1. CASE REPORT 
Nasopharyngeal carcinoma is a tumor that is often on the head and 
neck, but in pregnant women, will be a challenge in the management of 
antepartum patients with nasopharyngeal carcinoma when faced with 
adverse risks to the fetus and the mother. Cases of nasopharyngeal 
carcinoma in pregnancy are very rare in most countries (<1 per 100,000 per 
year), most obstetricians in developing countries are not accustomed to 
sufferers of nasopharyngeal carcinoma, both recognizing the clinical 
symptoms to their management during pregnancy. In addition, the diagnosis 
of these malignancies is generally very low and in particular in developing 
countries due to several factors such as lack of public awareness of these 
malignancies, poor health system, socio-cultural status, low socio-economic 
status, lack of access to health facilities and scarcity of facilities in terms of 
the treatment of this malignancy itself [1]. Until now, several studies have 
shown that patients with nasopharyngeal carcinoma in pregnancy can be 
managed well by using a multidisciplinary approach to improve the 
condition of mothers and babies [2]. 
23-year-old woman with 13 weeks gestational age came with 
complaints of a lump in both necks since 3 months. Patients complain of 
frequent nosebleeds in the past month, nasal congestion, headaches and full 
ears. His psychosocial history is a newly married young couple and this is 
the first pregnancy, there are family history (uncle) with lymph node 
malignancy (the patient does not understand the type of malignancy). 
Educational background; the patient graduated from Senior High School 
with support and good family interaction. Psychiatric history and mental 
status is no problem. 
On physical examination, it appears moderate pain and afebrile, blood 
pressure 110/60 mmHg. Bilateral neck mass, right level II-III size 4x4x3 cm 
and left level II-IV size 6x5x3 cm. Nasoendoscopy examination; 
macroscopically, the mass fills the nasopharynx to both choana. The 
eustachian tube ostium is covered by masses on both sides. Obstetrics and 
Gynecology examination results; uterine fundus height measuring 18 cm 
from the symphysis, no palpable contractions, bleeding or vaginal 
discharge, on examination of the palpable cervical pelvis and ultrasound 
seen a single intrauterine fetus alive. On laboratory tests of hemoglobin 11.3 
g/dl, hematocrit 34%, platelets 197,000/ul, leukocytes 8500/ul, BT 
coagulation profile 3.8 minutes, CT 8 minutes, ureum 19 mg/dl, creatinine 
0.7 micro mol/L, SGOT 20 u/L, SGPT 17 u/L. 
On November 20, 2019 a nasopharyngeal biopsy was performed with 
local anesthesia with histopathological results of a tumor consisting of 
inflammation cells of lymphocyte cells and tumor cell groups in the form of 
round, fine chromatin, small nuclei, and found cell mitosis according to 
differentiated non-keratin squamous cell carcinoma. A diagnosis of 
nasopharyngeal carcinoma was made, and the patient was classified as 
TxN3M0. The use of computer tomography is still considered due to 
patients with early trimester gestational age, an examination will be planned 
during the second trimester gestational age. Magnetic resonance imaging 
(MRI) examinations are expensive and not available. For further 
management, the patient is planned for radiotherapy to waiting for the 
results of a nasopharyngeal CT scan and gestational age until the second 
trimester of pregnancy. 
2. DISCUSSION 
Nasopharyngeal carcinoma is a rare malignancy, only 2% of all head 
and neck malignancies. There is a complex relationship between the role of 
genetics, environment, viruses and food factors as the etiology of this 
malignancy [3]. Historically, the first case of nasopharyngeal carcinoma was 
reported in 1901 with several clinical symptoms of cancer described in 1922 
[4]. In the research of Mu-Sheng Zeng et al. it is reported that the highest 
incidence of nasopharyngeal carcinoma is in endemic areas of the Epstein-
Barr virus (EBV), especially in South China, Southeast Asia, Japan and the 
Middle East/North Africa with an incidence of up to 50 cases per 100,000; 
whereas in western countries, the incidence is around 1/100,000. This 
malignancy is the third most common malignancy in men than women 
[5].Research shows that nasopharyngeal carcinoma affects all age groups, 
but often occurs at the age of 50-60 years, and less often at an early age. In 
addition, it is widely believed that Epstein Barr Virus infection is not enough 
to induce nasopharyngeal carcinoma and that there are other factors such as 
genetic factors playing an important role in the pathogenesis of 
nasopharyngeal carcinoma [6]. In this case, the patient is relatively young at 
the age of 23 years, with a history of a family member with another positive 
malignancy even though it is not a nasopharyngeal carcinoma, this supports 
the genetic factor hypothesis. 
Nasopharyngeal carcinoma is difficult to diagnose at an early stage 
because of the lack of symptoms and clinical signs. At presentation, 
nasopharyngeal carcinoma associated with hearing problems, serous otitis 
media, tinnitus, nasal obstruction, anosmia, bleeding, difficulty in 
swallowing and dysphonia, and even eye symptoms with diplopia and pain. 
The initial diagnosis is difficult to make because early signs and symptoms 
of this disease are not specific. Most of patients (60.6%) had recognized 
they already had a unilateral ear problem, the earliest sign of NPC, several 
months before diagnosis. Second and third most prevalent symptoms at 
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presentation were persistent nasal congestion and nasal blood secretion [7]. 
Painless lump or neck mass caused by cancer metastasis to the neck lymph 
nodes [8]. In case reports of patients with bilateral neck enlargement 
complaints, nosebleeds, ear fullness and headaches. In some studies, hearing 
loss is caused by the tumor itself[8].The literature explains that hearing loss 
is affected because this cancer is located in the Rosenmuller fossa near the 
eustachian tube ostium [9]. 
Diagnosis and management of nasopharyngeal carcinoma in pregnancy 
is a challenge for ENT doctors, starting from the diagnosis through biopsy, 
radiological investigation and subsequent management after diagnosis of 
nasopharyngeal carcinoma is established. Biopsy, this procedure is very 
important as a definitive diagnosis of a nasopharyngeal malignancy, can be 
associated with the possibility of bleeding and anesthetic effects associated 
with fetal risk. Several authors reported that general anesthesia for non-
obstetric operations during pregnancy is a challenge. Research shows that 
anesthesia in the early trimester is at risk for fetal abortion, whereas in the 
second trimester it is relatively safe from the risk of spontaneous abortion 
and premature birth, then the risk in the third trimester is relatively reduced 
compared to the second trimester. [10, 11]  Thus, biopsy using general 
anesthesia should be done at the end of the trimester second to minimize the 
incidence of premature fetuses or abortion. In addition, complications 
related to biopsy are bleeding. Risk of bleeding in pregnant women will 
increase with increasing gestational age, this is due to hormonal factors. 
Progesterone, a vasoactive hormone that is known to inhibit 
vasoconstriction, resulting uncontrolled bleeding or thromboembolic events 
during biopsy [12, 13]. In this case reports the patient is biopsy using local 
anesthetics which is conducted at the relatively early gestational age (13 
weeks). Biopsy is an initial procedure in making the diagnosis in each 
process of malignancy. The risks and benefits of this procedure should 
always be considered in pregnant women or in some circumstances, and this 
procedure should not be delayed because of the pregnancy status because it 
is very important to start further treatment.  
Radiological examination, both CT-scan and MRI can provide good 
information about the expansion of the tumor to other organs. The American 
Society of Clinical Oncology (2017) reports that CT scans of the head and 
thorax are safe during pregnancy because they do not directly expose the 
fetus to radiation. Although some literature states that radioactive exposure 
in pregnancy can have a negative effect during pregnancy in the form of 
fetal defects and the incidence of abortion, the incidence of fetal defects and 
abortion increases inversely with gestational age, the greater the gestational 
age, the smaller the incidence of fetal or abortion defects. The use of 
magnetic resonance imaging is preferable in terms of diagnostics during 
pregnancy. In this case reports, nasopharyngeal CT scans are not performed 
with consideration of the relatively young gestational age. The use of MRI 
is good but there are no facilities in our hospital. Anatomic pathology is 
mentioned as an appropriate diagnostic procedure. Other laboratory tests 
including a complete blood count, kidney and liver function tests, and 
coagulation profile are important. The results of abnormal liver function 
tests indicate the possibility of liver metastasis [8]. 
Macroscopically, nasopharyngeal carcinoma have varies features from 
smooth mucosal protrusions, nodular lumps with or without surface 
ulceration and the presence of infiltrative lesions [14]. Histologically, 
according to WHO cited by MU-Sheng Zeng and friends, nasopharyngeal 
carcinomas are classified in three types based on the degree of 
differentiation. Type 1. Keratinizing squamous cell carcinoma (SCC), this 
type mostly arises from ostium of the Eustachian tube in lateral wall of the 
nasopharynx. Umar and colleagues found that the incidence of keratinizing 
SCC around 5-10% of the total cases of nasopharyngeal carcinoma. In 
electron microscopy, differentiated keratin-producing cells are seen by 
intracellular bridges between cells. Nasopharyngeal carcinomas types 2 and 
3 are non-keratin squamous cell carcinomas with variations in cell 
differentiation from mature cells to anaplastic cells. Type 2 and 3 NPC are 
non-keratin producers. Nasopharyngeal carcinoma type 3 has very different 
cell types (clear cells, spindles, anaplastic). In addition, Mu-Sheng Zeng and 
colleagues reported that type 3 nasopharyngeal carcinoma was the most 
common type in endemic areas because it was related to environmental 
factors, EBV infection and the role of genetically susceptible individuals. In 
this case, histopathology results was a network of inflammatory lymphocyte 
cells and tumor cell groups in the form of round, fine chromatin, small nuclei 
partly, found mitosis of cells according to WHO type 2 classification. 
Managing head and neck cancers during pregnancy requires 
understanding about pregnancy-related knowledge, encompassing a triad of 
effects, (i) the etiological effect of pregnancy on cancer, (ii) the direct and 
indirect effects of cancer on pregnancy, and (iii) the effect of diagnostic and 
treatment modalities on pregnancy. Consideration must also be given to the 
ethical dilemmas of decision making [15]. The American Society of Clinical 
Oncology recommends several management options for nasopharyngeal 
carcinoma without affecting pregnancy. In general, there are several factors 
that must be considered before starting this cancer treatment during 
pregnancy including gestational age, tumor stage and a woman's desire to 
maintain her pregnancy. The main risk associated with cancer during 
pregnancy is premature birth/abortion. Horgan et al in his study mentioned 
that there was a relationship between preterm birth and the chemo-radiation 
in women with malignant head and neck tumors including nasopharyngeal 
carcinoma. According to the current protocol, nasopharyngeal carcinoma 
can be treated with chemotherapy, radiotherapy or with a combination of 
both, depending on the stage of the tumor. However, several studies have 
reported that concurrent chemo-radiotherapy is better than radiotherapy 
alone for patients at low risk. Thus, administration of neoadjuvant and/or 
adjuvant chemotherapy is a therapy that is still acceptable for patients at 
high risk. In pregnant women, chemotherapy or radiation is still a challenge. 
Several studies have shown that chemotherapy in the second and third 
trimesters is risky because it can inhibit intrauterine growth and increase the 
incidence of preterm birth and the presence of cardiotoxic effects on the 
mother and fetus. To date, there have been several studies examining the 
increase in complications of nasopharyngeal carcinoma with increasing 
gestational age, in that study the patient's condition worsened during 
pregnancy, but improved after delivery without chemotherapy or radiation. 
Further research is needed to evaluate the results of the study. The 
nasopharyngeal carcinoma management protocol recommends that stages I 
and II can be treated with radiotherapy alone because the prognosis is 
generally good, but for stages III and IV that have a poor prognosis should 
be given a combination of radio-chemotherapy. In this case, the patient as 
clinically at stage IV (TxN3M0).  
3. CONCLUSION 
Nasopharyngeal carcinoma in pregnancy is rare. Management of 
nasopharyngeal carcinoma in pregnancy is a dilemma for doctors. 
Regardless of the gestational age, the deteriorating patient's condition 
becomes the choice to continue the treatment of the cancer with the risk of 
premature birth, fetal defects or abortion. The use of diagnostic and 
therapeutic modalities such as radiology, histopathology, radiotherapy and 
chemotherapy is still a dilemma so multidisciplinary consideration is needed 
from several experienced experts. In areas or health facilities that are limited 
in resources, patients often present with tumors at an advanced stage. 
Nonetheless, doctors must diagnose early clinical symptoms of 
nasopharyngeal malignancies so that they can refer patients for proper 
management at a complete facility home in the management of this cancer. 
Increasing gestational age can worsen symptoms of nasopharyngeal 
carcinoma, but further research is needed on this finding. 
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